Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis
Abstract Background Blood eosinophil count has been proposed as a predictor of response to inhaled corticosteroid (ICS) in the prevention of acute exacerbations of COPD. An optimal threshold of blood eosinophil count for prescribing ICS has not been agreed. Doubt has been cast on the role by observa...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-019-1268-7 |
id |
doaj-424e82daa2944cb4bf239adaef748f48 |
---|---|
record_format |
Article |
spelling |
doaj-424e82daa2944cb4bf239adaef748f482021-01-03T12:07:36ZengBMCRespiratory Research1465-993X2020-01-0121111510.1186/s12931-019-1268-7Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysisTimothy H. Harries0Victoria Rowland1Christopher J. Corrigan2Iain J. Marshall3Lucy McDonnell4Vibhore Prasad5Peter Schofield6David Armstrong7Patrick White8Department of Public Health and Primary Care, School of Population Health & Environmental Sciences, King’s College LondonDepartment of Public Health and Primary Care, School of Population Health & Environmental Sciences, King’s College LondonDepartment of Asthma Allergy & Respiratory Science, King’s College LondonDepartment of Public Health and Primary Care, School of Population Health & Environmental Sciences, King’s College LondonDepartment of Public Health and Primary Care, School of Population Health & Environmental Sciences, King’s College LondonDepartment of Public Health and Primary Care, School of Population Health & Environmental Sciences, King’s College LondonDepartment of Public Health and Primary Care, School of Population Health & Environmental Sciences, King’s College LondonDepartment of Public Health and Primary Care, School of Population Health & Environmental Sciences, King’s College LondonDepartment of Public Health and Primary Care, School of Population Health & Environmental Sciences, King’s College LondonAbstract Background Blood eosinophil count has been proposed as a predictor of response to inhaled corticosteroid (ICS) in the prevention of acute exacerbations of COPD. An optimal threshold of blood eosinophil count for prescribing ICS has not been agreed. Doubt has been cast on the role by observational studies. The role of inhaled corticosteroids in this relationship, independent of long-acting bronchodilators, has not been examined. Methods We conducted a systematic review of post-hoc analyses of randomised controlled trials (RCTs) and observational studies examining three blood eosinophil thresholds and the independent role of ICS. Included studies were categorised by the form (relative or absolute count) and cut point of eosinophil threshold used. Thresholds assessed were relative eosinophil count of 2%, and absolute counts of 150 cells/μL and 300 cells/μL. Three meta-analyses of the effect of ICS use in post-hoc analyses of RCTs based on these counts were carried out. Initial analysis included all studies of ICS vs. any non-ICS regimen. Further analysis examined the effect of ICS, independent of the effect of long-acting bronchodilators. Results Sixteen studies examined the association between blood eosinophil count and response of exacerbation risk to ICS, in COPD patients. Eleven studies (25,881 patients) were post-hoc analyses of RCTs. Five studies (109,704 patients) were retrospective observational studies. The independent effect of ICS on the reduction of exacerbation risk was 20% at ≥2% blood eosinophil threshold (RR, 0.80; 95% CI, 0.74–0.85), 35% at ≥150 cells/μL blood eosinophil threshold (RR, 0.65; 0.52–0.79), and 39% at ≥300 cells/μL blood eosinophil threshold (RR, 0.61; 0.44–0.78). No association was found in four out of five observational studies. Conclusion This is the first systematic review to assess, in post-hoc analyses of RCTs, the independent effect of ICS in reducing the risk of COPD exacerbation across a range of blood eosinophil thresholds. Association between ICS prescription and reduced exacerbation risk at these thresholds was confirmed. The lack of association found in the observational studies questions the relevance of these observations to a “real world” COPD population. To clarify the clinical utility of this biomarker, the association should be tested in prospective effectiveness studies.https://doi.org/10.1186/s12931-019-1268-7Pulmonary disease, chronic obstructiveEosinophilsInhaled corticosteroidsRandomised controlled trialsObservational studies |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Timothy H. Harries Victoria Rowland Christopher J. Corrigan Iain J. Marshall Lucy McDonnell Vibhore Prasad Peter Schofield David Armstrong Patrick White |
spellingShingle |
Timothy H. Harries Victoria Rowland Christopher J. Corrigan Iain J. Marshall Lucy McDonnell Vibhore Prasad Peter Schofield David Armstrong Patrick White Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis Respiratory Research Pulmonary disease, chronic obstructive Eosinophils Inhaled corticosteroids Randomised controlled trials Observational studies |
author_facet |
Timothy H. Harries Victoria Rowland Christopher J. Corrigan Iain J. Marshall Lucy McDonnell Vibhore Prasad Peter Schofield David Armstrong Patrick White |
author_sort |
Timothy H. Harries |
title |
Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis |
title_short |
Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis |
title_full |
Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis |
title_fullStr |
Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis |
title_full_unstemmed |
Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis |
title_sort |
blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing copd exacerbations in post-hoc rct and observational studies: systematic review and meta-analysis |
publisher |
BMC |
series |
Respiratory Research |
issn |
1465-993X |
publishDate |
2020-01-01 |
description |
Abstract Background Blood eosinophil count has been proposed as a predictor of response to inhaled corticosteroid (ICS) in the prevention of acute exacerbations of COPD. An optimal threshold of blood eosinophil count for prescribing ICS has not been agreed. Doubt has been cast on the role by observational studies. The role of inhaled corticosteroids in this relationship, independent of long-acting bronchodilators, has not been examined. Methods We conducted a systematic review of post-hoc analyses of randomised controlled trials (RCTs) and observational studies examining three blood eosinophil thresholds and the independent role of ICS. Included studies were categorised by the form (relative or absolute count) and cut point of eosinophil threshold used. Thresholds assessed were relative eosinophil count of 2%, and absolute counts of 150 cells/μL and 300 cells/μL. Three meta-analyses of the effect of ICS use in post-hoc analyses of RCTs based on these counts were carried out. Initial analysis included all studies of ICS vs. any non-ICS regimen. Further analysis examined the effect of ICS, independent of the effect of long-acting bronchodilators. Results Sixteen studies examined the association between blood eosinophil count and response of exacerbation risk to ICS, in COPD patients. Eleven studies (25,881 patients) were post-hoc analyses of RCTs. Five studies (109,704 patients) were retrospective observational studies. The independent effect of ICS on the reduction of exacerbation risk was 20% at ≥2% blood eosinophil threshold (RR, 0.80; 95% CI, 0.74–0.85), 35% at ≥150 cells/μL blood eosinophil threshold (RR, 0.65; 0.52–0.79), and 39% at ≥300 cells/μL blood eosinophil threshold (RR, 0.61; 0.44–0.78). No association was found in four out of five observational studies. Conclusion This is the first systematic review to assess, in post-hoc analyses of RCTs, the independent effect of ICS in reducing the risk of COPD exacerbation across a range of blood eosinophil thresholds. Association between ICS prescription and reduced exacerbation risk at these thresholds was confirmed. The lack of association found in the observational studies questions the relevance of these observations to a “real world” COPD population. To clarify the clinical utility of this biomarker, the association should be tested in prospective effectiveness studies. |
topic |
Pulmonary disease, chronic obstructive Eosinophils Inhaled corticosteroids Randomised controlled trials Observational studies |
url |
https://doi.org/10.1186/s12931-019-1268-7 |
work_keys_str_mv |
AT timothyhharries bloodeosinophilcountamarkerofinhaledcorticosteroideffectivenessinpreventingcopdexacerbationsinposthocrctandobservationalstudiessystematicreviewandmetaanalysis AT victoriarowland bloodeosinophilcountamarkerofinhaledcorticosteroideffectivenessinpreventingcopdexacerbationsinposthocrctandobservationalstudiessystematicreviewandmetaanalysis AT christopherjcorrigan bloodeosinophilcountamarkerofinhaledcorticosteroideffectivenessinpreventingcopdexacerbationsinposthocrctandobservationalstudiessystematicreviewandmetaanalysis AT iainjmarshall bloodeosinophilcountamarkerofinhaledcorticosteroideffectivenessinpreventingcopdexacerbationsinposthocrctandobservationalstudiessystematicreviewandmetaanalysis AT lucymcdonnell bloodeosinophilcountamarkerofinhaledcorticosteroideffectivenessinpreventingcopdexacerbationsinposthocrctandobservationalstudiessystematicreviewandmetaanalysis AT vibhoreprasad bloodeosinophilcountamarkerofinhaledcorticosteroideffectivenessinpreventingcopdexacerbationsinposthocrctandobservationalstudiessystematicreviewandmetaanalysis AT peterschofield bloodeosinophilcountamarkerofinhaledcorticosteroideffectivenessinpreventingcopdexacerbationsinposthocrctandobservationalstudiessystematicreviewandmetaanalysis AT davidarmstrong bloodeosinophilcountamarkerofinhaledcorticosteroideffectivenessinpreventingcopdexacerbationsinposthocrctandobservationalstudiessystematicreviewandmetaanalysis AT patrickwhite bloodeosinophilcountamarkerofinhaledcorticosteroideffectivenessinpreventingcopdexacerbationsinposthocrctandobservationalstudiessystematicreviewandmetaanalysis |
_version_ |
1724350789253595136 |